Covidien Announces Effectiveness Of Mallinckrodt Form 10 Registration Statement
Covidien (NYSE: COV), a leading global provider of healthcare products,
today announced that the Securities and Exchange Commission (SEC) has
declared effective the Registration Statement on Form 10 filed by
Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.